Exclusive: Orakl Oncology raises $34m to test cancer drugs on ‘virtual patients’
Swedish investor Norrsken and Paris-based VC Singular co-led the round
Sifted AI3 min read
1 story
Swedish investor Norrsken and Paris-based VC Singular co-led the round
Showing 1 of 1 stories
You're all caught up.
Get the top AI news and tools straight to your inbox every week.
Weekly · AI news
Join 15,000+ AI enthusiasts